This final rule considers public comments submitted in response to the proposed rule revising the WIC food packages published on Nov. 21, 2022.
This is a reinstatement, with changes, of a previously approved information collection that was discontinued on 12/31/2022. This data collection effort for the Special Supplemental Nutrition Program for Women, Infants and Children Participant and Program Characteristics Study.
In accordance with the Paperwork Reduction Act of 1995, this notice invites the general public and other public agencies to comment on this proposed information collection.
USDA announces adjusted income eligibility guidelines to be used by state agencies in determining the income eligibility of persons applying to participate in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). These income eligibility guidelines are to be used in conjunction with the WIC regulations.
This rulemaking serves to amend WIC program regulations by incorporating provisions of the Access to Baby Formula Act of 2022 and making related amendments.
USDA FNS is proposing to add a new system of records, entitled USDA/FNS–13, Mercury, which is a Consumer Off the Shelf workflow system designed to automate the correspondence tracking and management process within FNS.
This agenda provides summary descriptions of significant and not significant regulations being developed in FNS.
This study informs USDA FNS about the reasons behind under-redemption of the cash-value benefit (CVB) issued to participants in WIC.
The FNS WIC Participant and Program Characteristics Study report describes demographic, income, breastfeeding, and health-related information of a census of WIC participants as well as information on the benefits they receive through WIC.
The purpose of this new collection is to collect qualitative and quantitative stakeholder feedback through meetings, focus groups, interviews, other stakeholder interactions and surveys, as well as requests for administrative data, as part of the planning process for FNS regulatory actions, the semi-annual regulatory agenda, research studies, outreach, training and the development of guidance.